Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic ...
In October 2026, Illumina announced SpliceAI2, a new genomic AI model that helps researchers better identify disease-relevant ...
Illumina introduced SpliceAI2 on October 8, 2026, a genomic AI model from its BioInsight AI Lab that predicts how genetic ...
The list of tools includes SpliceA12, a new iteration of a genomic AI model designed to identify disease-relevant splice ...
Music creation platform Splice announces an AI deal with ElevenLabs, integrating the latter’s music models into its music production workflows. Music creation platform Splice has announced an AI deal ...
Illumina, Inc. introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic variation. SpliceAI2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results